Current and historical daily PE Ratio for Sansure Biotech Inc (
SHSE:688289
) from 2020 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sansure Biotech stock (SHSE:688289) PE ratio as of May 22 2024 is 30.77.
More Details
Sansure Biotech Inc (SHSE:688289) PE Ratio (TTM) Chart
Sansure Biotech Inc (SHSE:688289) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 902
- 1
- 2
- 3
- 4
- 5
- 6
- 11
| Sansure Biotech PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-22 | 30.8 | 2024-03-13 | 32.7 |
| 2024-05-21 | 30.8 | 2024-03-12 | 33.0 |
| 2024-05-20 | 30.8 | 2024-03-11 | 33.2 |
| 2024-05-17 | 30.5 | 2024-03-08 | 32.3 |
| 2024-05-16 | 30.2 | 2024-03-07 | 32.7 |
| 2024-05-15 | 30.3 | 2024-03-06 | 33.3 |
| 2024-05-14 | 30.8 | 2024-03-05 | 34.4 |
| 2024-05-13 | 30.5 | 2024-03-04 | 34.9 |
| 2024-05-10 | 31.2 | 2024-03-01 | 34.9 |
| 2024-05-09 | 31.5 | 2024-02-29 | 35.2 |
| 2024-05-08 | 31.4 | 2024-02-28 | 33.6 |
| 2024-05-07 | 31.3 | 2024-02-27 | 34.2 |
| 2024-05-06 | 31.6 | 2024-02-26 | 32.9 |
| 2024-04-30 | 31.0 | 2024-02-23 | 32.8 |
| 2024-04-29 | 30.6 | 2024-02-22 | 32.3 |
| 2024-04-26 | 28.9 | 2024-02-21 | 32.1 |
| 2024-04-25 | 28.5 | 2024-02-20 | 32.7 |
| 2024-04-24 | 28.3 | 2024-02-19 | 32.4 |
| 2024-04-23 | 28.0 | 2024-02-08 | 32.7 |
| 2024-04-22 | 27.8 | 2024-02-07 | 31.8 |
| 2024-04-19 | 27.9 | 2024-02-06 | 31.1 |
| 2024-04-18 | 27.8 | 2024-02-05 | 28.9 |
| 2024-04-17 | 27.6 | 2024-02-02 | 28.1 |
| 2024-04-16 | 27.6 | 2024-02-01 | 28.1 |
| 2024-04-15 | 28.1 | 2024-01-31 | 29.0 |
| 2024-04-12 | 27.4 | 2024-01-30 | 30.3 |
| 2024-04-11 | 27.8 | 2024-01-29 | 31.3 |
| 2024-04-10 | 28.1 | 2024-01-26 | 31.0 |
| 2024-04-09 | 29.0 | 2024-01-25 | 31.1 |
| 2024-04-08 | 28.5 | 2024-01-24 | 28.8 |
| 2024-04-03 | 29.2 | 2024-01-23 | 28.9 |
| 2024-04-02 | 29.2 | 2024-01-22 | 28.4 |
| 2024-04-01 | 29.3 | 2024-01-19 | 30.1 |
| 2024-03-29 | 29.2 | 2024-01-18 | 29.8 |
| 2024-03-28 | 28.9 | 2024-01-17 | 30.3 |
| 2024-03-27 | 30.9 | 2024-01-16 | 30.6 |
| 2024-03-26 | 31.4 | 2024-01-15 | 31.6 |
| 2024-03-25 | 32.6 | 2024-01-12 | 30.8 |
| 2024-03-22 | 33.4 | 2024-01-11 | 30.7 |
| 2024-03-21 | 33.4 | 2024-01-10 | 29.9 |
| 2024-03-20 | 34.1 | 2024-01-09 | 30.4 |
| 2024-03-19 | 34.3 | 2024-01-08 | 30.6 |
| 2024-03-18 | 35.0 | 2024-01-05 | 31.1 |
| 2024-03-15 | 33.5 | 2024-01-04 | 31.6 |
| 2024-03-14 | 33.0 | 2024-01-03 | 31.5 |
Sansure Biotech Inc (SHSE:688289) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Sansure Biotech Inc
ISIN : CNE1000043J1
Share Class Description:
SHSE:688289: Class ACompare
Compare
Traded in other countries / regions
688289.China IPO Date
2020-08-28Description
Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers